BRCA 1 and BRCA2 in breast cancer families from Wales: Moderate mutation frequency and two recurrent mutations in BRCA 1

British Journal of Cancer

Volumn 78, Issue 11, 1998, Pages 1417-1420

  Lancaster, J M ^a   Carney, M E ^a   Gray, J ^b   Myring, J ^b   Gumbs, C ^a   Sampson, J ^b   Wheeler, D ^b   France, E ^b   Wiseman, R ^c   Harper, P ^b   Futreal, P A ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

BRCA1; BRCA2; Breast and ovarian cancer; Wales

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MUTATION RATE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; UNITED KINGDOM; BREAST TUMOR; ETHNOLOGY; FAMILIAL CANCER; FRAMESHIFT MUTATION; GENETICS; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; FRAMESHIFT MUTATION; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS; WALES;

EID: 0031597429     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.701     Document Type: Article

References (21)

1. Ashley DJB (1986) Welshness and disease. In Genetic and Population Studies in Wales. Harper PS (ed.). University of Wales Press: Cardiff
2. Campbell IG, Schroff R, Englefield P and Eccles DM (1997) BRCA1 polymorphisms. Br J Cancer 75: 1854-1855
3. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS and Weber BL (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8: 387-391
4. Cheadle JP, Goodchild MC and Meredith AL (1993) Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales. Hum Mol Genet 2: 1551-1556
5. Hakansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H and Borg A (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078
6. Johannsson O, Ostermeyer EA, Hakansson S, Friedman LS, Johansson U, Sellberg G, Brondum-Nielsen K, Sele V, Olsson H, King MC and Borg A (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 58: 441-450
7. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wisemann R, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton M and Futreal PA (1996a) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240
8. Lancaster JM, Cochran CJ, Browlee HA, Berchuck A, Futreal PA and Wiseman RW (1996b) Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test. J Natl Cancer Inst 88: 552-554
9. Lancaster JM, Futreal A, Berchuck A and Wiseman RW (1997) The dideoxy fingerprinting assay for BRCA1 mutation analysis. Mol Carcinog 19: 176-179
10. Lucotte G and Hazout S (1995) Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles. Hum Biol 67: 562-576
11. Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BA and Lenoir GM (1996) A polymorphic stop codon in BRCA2. Nature Genet 13: 245-247
12. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Borgden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrision P, Roseteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
13. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM and the Breast Cancer Linkage Consortium (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56: 254-264
14. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D and Offit K (1996a) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet 13: 126-128
15. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC and Goldgar DE (1996b) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58: 271-280
16. Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, Neuhausen S, Skolnick M, Norton L and Goldgar D (1996) Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347: 1643-1645
17. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Gross P, Anderson D, Larsson C, Narod SA and Futreal PA (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet 13: 120-122
18. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT and Lenoir GM (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60: 486-495
19. Szabo C and King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60: 1013-1020
20. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM and Eyfjord JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet 13: 117-119
21. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gumbs C, Mickle G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Ellese R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenor G, Egilsson V, Barkadottir RB, Eason DF, Bentley DR, Futreal PA, Ashworth A and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792